Charles Schwab Investment Management Inc. acquired a new stake in MBX Biosciences, Inc. (NYSE:MBX – Free Report) in the 4th ...
A new study led by Dr. Hilla Chen from the Koret School of Veterinary Medicine at Hebrew University, recently published in ...
13d
Clinical Trials Arena on MSNAstraZeneca’s $1bn hypoparathyroidism drug achieves success at Phase IIIAstraZeneca acquired the hypoparathyroidism therapy eneboparatide as part of a buyout of Amolyt Pharma in July 2024.
Pariacalcitol is a type of vitamin D and is believed to be a positive way to manage CKD complications.
High ionized calcium levels were associated with an increased risk for hyperparathyroidism, especially among men.
Septerna Provides Corporate Overview and Reports Fourth Quarter and Full Year 2024 Financial Results
Preclinical Work Advancing with Plans to Select a Next-Generation Oral Small Molecule PTH1R Agonist to Accelerate Toward the Clinic Later This ...
manifested by intact parathyroid hormone levels below normal. We aimed to evaluate intact parathyroid hormone levels both during normocalcemia and at hypocalcemia, in this population. Study Design ...
How well do injection protocols affect the progression of osteoporosis in bone? A new study from a group of Swiss researchers ...
Equities researchers at StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ ...
A new study led by Dr. Hilla Chen, Prof. Gilad Segev and Dr. Michal Mazaki-Tovi from the Koret School of Veterinary Medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results